# 62135-737-90 · Flurazepam Hydrochloride Capsule · Chartwell Molecular Holdings LLC — FDA drug shortage duration tracker

For 62135-737-90 · Flurazepam Hydrochloride Capsule · Chartwell Molecular Holdings LLC, package ndc is 62135-737-90; generic name is Flurazepam Hydrochloride Capsule; manufacturer is Chartwell Molecular Holdings LLC; status is Current; availability now is Available, recorded from its source on 2026-09-01; source re-checked 2026-09-09.

- **Package NDC:** 62135-737-90 _(verified: appears in the quote below)_
- **Generic name:** Flurazepam Hydrochloride Capsule _(verified: appears in the quote below)_
- **Manufacturer:** Chartwell Molecular Holdings LLC _(verified: appears in its own passage below)_
- **Status:** Current _(verified: appears in its own passage below)_
- **Availability now:** Available _(verified: appears in the quote below)_
- **Initial posting date:** 08/03/2022 _(verified: appears in the quote below)_
- **Last update date:** 08/26/2026 _(verified: appears in its own passage below)_
- **Days in shortage:** 1490 _(our reading, not quoted from the source)_
- **Dosage form:** Capsule _(verified: appears in its own passage below)_
- **Therapeutic category:** Neurology _(verified: appears in its own passage below)_

## What the source says

> "initial_posting_date": "08/03/2022", "package_ndc": "62135-737-90", "generic_name": "Flurazepam Hydrochloride Capsule", "contact_info": "845-268-5000 Ext. 510", "availability": "Available"

## Where each value comes from

This source states these in separate places, so each value is shown with the passage that states it.

### Manufacturer

> "update_date": "08/26/2026", "therapeutic_category": [ "Neurology", "Other" ], "dosage_form": "Capsule", "presentation": "Flurazepam Hydrochloride, Capsule, 30 mg (NDC 62135-737-90)", "company_name": "Chartwell Molecular Holdings LLC", "status": "Current"

### Status

> "update_date": "08/26/2026", "therapeutic_category": [ "Neurology", "Other" ], "dosage_form": "Capsule", "presentation": "Flurazepam Hydrochloride, Capsule, 30 mg (NDC 62135-737-90)", "company_name": "Chartwell Molecular Holdings LLC", "status": "Current"

### Last update date

> "update_date": "08/26/2026", "therapeutic_category": [ "Neurology", "Other" ], "dosage_form": "Capsule", "presentation": "Flurazepam Hydrochloride, Capsule, 30 mg (NDC 62135-737-90)", "company_name": "Chartwell Molecular Holdings LLC", "status": "Current"

### Dosage form

> "update_date": "08/26/2026", "therapeutic_category": [ "Neurology", "Other" ], "dosage_form": "Capsule", "presentation": "Flurazepam Hydrochloride, Capsule, 30 mg (NDC 62135-737-90)", "company_name": "Chartwell Molecular Holdings LLC", "status": "Current"

### Therapeutic category

> "update_date": "08/26/2026", "therapeutic_category": [ "Neurology", "Other" ], "dosage_form": "Capsule", "presentation": "Flurazepam Hydrochloride, Capsule, 30 mg (NDC 62135-737-90)", "company_name": "Chartwell Molecular Holdings LLC", "status": "Current"

## Source

- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Chartwell%20Molecular%20Holdings%20LLC%22+AND+generic_name%3A%22Flurazepam%20Hydrochloride%20Capsule%22+AND+status%3A%22Current%22&limit=1000

Last verified: 2026-09-09. Review by: 2026-09-12.
Part of [FDA drug shortage duration tracker](https://referencesource.org/drug-shortage-duration-tracker/).